Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Longevity Biotech Australia Pty Ltd (subsidiary)

Clinical trials sponsored by Longevity Biotech Australia Pty Ltd (subsidiary), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a synthetic peptide offer a new way to tackle Parkinson's? Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a synthetic peptide offer a new way to tackle Parkinson's?

Disease control Recruiting now

This early-stage trial evaluates the safety and tolerability of an investigational drug called LBT-3627, a synthetic peptide, in healthy adults and in people with Parkinson's disease. Participants receive either the drug or a placebo, and researchers monitor side effects and how …

Phase 1 • Sponsor: Longevity Biotech Australia Pty Ltd (subsidiary) • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC